NTRA

#401
Natera, Inc. - Common Stock
223.3 7 USD
+4.31%
부문: 헬스케어
베이스: USD
수익 통화: USD
일일 변동 비율
223.37
223.37
년간 변동
131.81
256.27
일일 변동
+4.31%
월간 변동
+13.17%
6달 변화
-6.39%
년간 변동율
+41.82%
이전 종가
214.1 4
Open
223.3 7
저가
223.3 7
High
223.3 7
양
212
전체 차트 열기 Full chart

Financials

개요 성명 통계
4분기 연간
  • Market Capitalization 31.99 B
  • Employee 6 140
  • Founded 2004
  • CEO Steven Chapman
  • Website www.natera.com
  • Headquarter Delaware, United States
  • FIGI BBG001J1BQ86
  • Industry 분석 & 리서치
총매출
순이익
주당 순이익(기본 EPS)
총부채
잉여 현금 흐름
현금 및 현금성 자산
주가수익비율
-150.72
주가매출액비율
13.58

Natera, Inc. - Common Stock

Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA testing technology, with a focus on women's health, cancer, and organ health. Natera's proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tube of blood. Natera operates CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments in San Carlos, California and Austin, Texas.

뉴스